Skip to main content
MedicHelpLine
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALStandard

FINTEPLA

FENFLURAMINE HYDROCHLORIDE

Standard Dose
EQ 2.2MG BASE/ML
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary

Approval overview FINTEPLA is listed in Drugs@FDA under application 212102 (NDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient FENFLURAMINE HYDROCHLORIDE Form and strength SOLUTION;ORAL - EQ 2.2MG BASE/ML Sponsor UCB INC Submission history Latest submission status date: 2025-10-15 00:00:00.

Structured Monograph

Clinical summary

Approval overview FINTEPLA is listed in Drugs@FDA under application 212102 (NDA). Review priority: STANDARD Marketing status: Prescription Active ingredient FENFLURAMINE HYDROCHLORIDE Form and strength SOLUTION;ORAL - EQ 2.2MG BASE/ML Sponsor UCB INC Submission history Latest submission status date: 2025-10-15 00:00:00. Submission type: SUPPL.

Monitoring

  • Marketing status: Prescription
  • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.
FINTEPLA (FENFLURAMINE HYDROCHLORIDE) | Drug Monograph | MedicHelpline